Ovarian Health Risk Assessment: A Review of Our Comprehensive UK Package
Explore our comprehensive ovarian health risk assessment package available in the UK. Learn what biomarkers are tested, who should consider screening, and how results are interpreted.
Ovarian health risk assessment can help some women understand selected biomarkers related to their long-term wellbeing. Our nurse-led service provides blood-based ovarian health screening to help women in London and across the UK access clear, evidence-informed information about their health.
Because some ovarian symptoms can be subtle or non-specific, proactive blood testing may offer insight into biomarker levels that warrant further discussion with an appropriate healthcare professional. It should not be used instead of clinical assessment where symptoms are present.
What Is an Ovarian Health Risk Assessment?
An ovarian health risk assessment is a structured blood screening process that measures specific biological markers associated with ovarian function and cellular activity. It is designed to provide an informational baseline, helping women understand their current risk profile.
In clinical blood testing, ovarian risk assessment typically involves measuring key biomarkers such as CA125 and HE4 — proteins that may be elevated in association with certain ovarian conditions. These results are interpreted within the context of an individual’s age, hormonal stage, and personal health history.
Quick answer: An ovarian health risk assessment is a blood-based screening process that analyses specific biomarkers, including CA125 and HE4, to help identify potential areas of concern relating to ovarian health. Results may indicate the need for further clinical evaluation by an appropriate healthcare professional.
Key Biomarkers Included in Our Ovarian Health Screening Package
Understanding what is being tested — and why — is central to making an informed decision about screening. Below is an overview of the primary biomarkers assessed as part of our ovarian health package:
CA125 (Cancer Antigen 125)
CA125 is a protein found on the surface of many ovarian cells. Elevated levels can sometimes be associated with ovarian-related conditions, though levels may also rise due to endometriosis, fibroids, menstruation, or benign cysts. A raised CA125 result does not confirm a diagnosis — it suggests that further evaluation by a healthcare professional may be appropriate.
HE4 (Human Epididymis Protein 4)
HE4 is often used alongside CA125 as a more specific biomarker. Some research published in peer-reviewed literature suggests HE4 may offer greater specificity alongside CA125 in certain populations, particularly premenopausal women, though clinical interpretation should always be conducted by an appropriately qualified healthcare professional. Individual results may vary.
ROMA Score (Risk of Ovarian Malignancy Algorithm)
Where both CA125 and HE4 are measured, a ROMA score may be calculated. This algorithm combines the two biomarker values alongside menopausal status to produce a risk stratification index — expressed as low, intermediate, or elevated risk — which provides a more nuanced picture than a single biomarker alone.
Practical Insight: Biomarker results exist on a spectrum. A single elevated marker does not constitute a diagnosis and should always be interpreted in a broader clinical context. Our team provides clear written reports to support any follow-up conversations with healthcare professionals.
Who Should Consider an Ovarian Health Risk Assessment?
While ovarian health screening can benefit a broad range of women, certain groups may find it particularly useful as part of a proactive wellbeing plan:
- Women aged 40 and over, particularly those approaching or in perimenopause
- Women with a family history of ovarian, breast, or colorectal conditions
- Women experiencing persistent, unexplained symptoms such as bloating, pelvic discomfort, or changes in bladder habits — who should seek medical advice promptly
- Women who have previously had abnormal gynaecological findings
- Women seeking a baseline health reference point for ongoing monitoring
- Women with BRCA1 or BRCA2 gene variants (who should also be under the care of appropriate clinical specialists)
Important: If you are experiencing significant or persistent symptoms, we encourage you to seek appropriate medical advice rather than relying on screening results alone.
For women interested in a broader view of hormonal and reproductive health, women’s health blood tests can provide additional context alongside ovarian screening markers.
Ovarian Screening: NHS vs Private Options in the UK
Many women in London and across the UK are unaware of the differences between NHS-available testing and private ovarian health screening. The table below provides a factual, neutral comparison:
| Feature | NHS Testing | Private Screening (Our Clinic) |
|---|---|---|
| Referral Required | Yes – GP referral typically required | No – self-referral available |
| Wait Time | Variable; can be several weeks | Private appointment availability varies |
| Test Scope | Symptom-driven or high-risk only | Available to adult women where the test is suitable for their circumstances |
| ROMA Score Calculation | Not routinely offered | Included where appropriate |
| Results Report | Via GP or hospital | Detailed written report provided |
| Treatment/Prescriptions | Available through NHS pathway | Not provided — testing and reporting only |
Practical Insight: NHS services remain an essential and trusted part of UK healthcare. Private screening complements — not replaces — NHS care by offering accessible, timely information for those who wish to take a proactive approach to their health.
Understanding Your Results: What the Numbers May Mean
Receiving a blood test result can feel daunting without clear context. Here is a brief guide to interpreting the types of results you may receive:
- Within reference range: Biomarker levels fall within the standard reference range for your age and menopausal status. This can offer reassurance, though it does not rule out all conditions.
- Mildly elevated: Levels are above the reference range but not significantly so. This may reflect benign causes such as endometriosis, fibroids, or recent menstruation, and may be worth monitoring or discussing with a healthcare professional.
- Significantly elevated: Levels are notably raised. This does not confirm a diagnosis but suggests that timely discussion with an appropriate healthcare professional is recommended.
Our reporting includes clear explanations of your biomarker values alongside reference ranges, helping you understand what your results may suggest. Explore our guide to health screening reports and interpretation for more information on how we present results.
How Often Should You Consider Ovarian Health Screening?
There is no single universal guideline for the frequency of ovarian health blood testing in the UK, as it is not currently part of the NHS national screening programme. However, for women choosing private screening proactively, the following general principles may be useful:
- Annual testing is commonly chosen by women with a family history or those tracking ongoing biomarker trends
- Every 2 years may be appropriate for women with no elevated risk factors seeking general health awareness
- Following an elevated result, more frequent re-testing may be advisable — always in consultation with an appropriate healthcare professional
Practical Insight: Trending results over time can sometimes be more informative than a single data point. Keeping a record of previous test results helps create a personal health baseline for future comparison.
Ovarian Health Screening in London: Accessing Our Service
Our clinic is conveniently located and accessible to women across London and the wider South East. We offer a calm, professional environment staffed by experienced nurses who understand the importance of clear communication and patient dignity.
There is no GP referral required to book an ovarian health risk assessment with us, subject to suitability for this private testing service. You can book directly through our website, choose an available appointment, and receive a detailed written report. Prices for our screening packages are listed on our website; please note that final costs may vary depending on your individual requirements, and a full breakdown of costs will be confirmed prior to your appointment.
For women seeking a more comprehensive overview of their health, our full body health screening packages allow ovarian markers to be assessed alongside a wider range of health indicators.
Frequently Asked Questions: Ovarian Health Risk Assessment UK
What is an ovarian health risk assessment and what does it involve?
An ovarian health risk assessment is a blood-based screening process that measures specific biomarkers — primarily CA125 and HE4 — associated with ovarian health. A small blood sample is taken, analysed, and interpreted within the context of your age and menopausal status, producing a clear written report.
Is an ovarian health blood test the same as an ovarian cancer test?
Not exactly. Biomarkers such as CA125 and HE4 can sometimes be elevated in association with ovarian conditions, but they are not diagnostic tests for cancer. Elevated results may indicate the need for further evaluation by an appropriate healthcare professional.
Can I have an ovarian risk assessment without a GP referral in the UK?
Yes. Our private nurse-led clinic does not require a GP referral. You can self-refer and book an appointment directly through our website.
What does a raised CA125 level mean?
A raised CA125 level can sometimes suggest ovarian-related changes, but it may also be elevated due to benign causes such as endometriosis, fibroids, pelvic inflammatory conditions, or even menstruation. It does not confirm a diagnosis and should be discussed with a healthcare professional.
How long does it take to receive results from an ovarian health risk assessment?
Results are typically available within a few working days of your blood test appointment. You will receive a detailed written report explaining your biomarker values and reference ranges.
Is this screening suitable for younger women?
Ovarian health screening can be considered by adult women of any age, though it may be most relevant for those aged 35 and over, or those with a family history of ovarian or related conditions. We recommend discussing your individual circumstances before booking.
Does the ovarian health risk assessment include a scan or internal examination?
No. Our service is entirely blood-based. We do not offer ultrasound scans, internal examinations, or any form of diagnostic imaging. If these are required, your healthcare professional will arrange referral through appropriate services.
What happens if my results suggest an elevated risk?
Our written report will clearly indicate any results outside the reference range and will encourage you to discuss findings with an appropriate healthcare professional. We do not offer prescriptions, diagnoses, or treatment — our role is to provide accurate, clear information.
How is private ovarian screening in London different from NHS testing?
NHS ovarian testing is typically symptom-driven or offered to high-risk individuals via GP referral. Private screening at our London clinic is available by self-referral for women seeking additional information about ovarian health biomarkers, subject to suitability.
Can I combine ovarian health screening with other women’s health blood tests?
Yes. We offer a range of women’s health blood tests that can be combined with ovarian biomarker screening to give a broader picture of hormonal and overall health.
Take a Proactive Step Towards Ovarian Health Awareness
Understanding your health profile can be part of a proactive approach to long-term wellbeing. If you are curious about selected ovarian health biomarkers and would like an evidence-informed baseline, our ovarian health screening package may be an option to consider.
You can self-refer and book a suitable appointment at our London clinic. You will receive a written report explaining your biomarker results and reference ranges; any symptoms or concerning results should be discussed with an appropriate healthcare professional.
Explore our ovarian health risk assessment and other available screening packages when you are ready to compare options.
Disclaimer
This article is for educational information only and is not medical advice, diagnosis, or treatment. Health Screening Clinic provides testing and reporting only; we do not prescribe, treat, or guarantee outcomes. Please discuss symptoms, concerns, or abnormal results with an appropriate qualified healthcare professional.